Fidelity Advisor Biotechnology Fund NBIX Holdings History
Fidelity Advisor Biotechnology Fund's Neurocrine Biosciences Inc Holding Summary
As of 2025-04-30, FIDELITY ADVISOR SERIES VII held 273,700.00 shares of Neurocrine Biosciences Inc(NBIX), totaling $29.47 Mil. This investment constitutes 2.17% of their stock portfolio, and FIDELITY ADVISOR SERIES VII now holds 0.28% of the outstanding Neurocrine Biosciences Inc(NBIX) stock.
The initial trade took place in 2019Q4. And since then Fidelity Advisor Biotechnology Fund has made 4 purchases of NBIX, at an average price of $101.94, for a total of 1.19 Mil shares. In addition, there have been 4 sales at an average price of $99.62 for 917,352.00 shares. Based on historical transaction data and NBIX's current price of $132.02, Fidelity Advisor Biotechnology Fund's estimated gain on his NBIX holdings is $6.11 Mil, reflecting a 5.03% gain to date.
Fidelity Advisor Biotechnology Fund NBIX ($132.02) Holding Chart
Fidelity Advisor Biotechnology Fund NBIX ($132.02) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
